Influence of Acupuncture to Ocular Microcirculation in Patients With Diabetes Mellitus
Launched by TECHNISCHE UNIVERSITÄT DRESDEN · Nov 30, 2009
Trial Information
Current as of June 18, 2025
Unknown status
Keywords
ClinConnect Summary
Diabetes is combined with severe vascular damage at the different stages of the disease, causing reduction in retinal perfusion. Acupuncture is supposed to regulate the perfusion. We propose a study to evaluate the effect of acupuncture to the vascular auto regulation in patient with Diabetes, compared to healthy people without vascular or retinal diseases. The perfusion of the retinal vessel will be examined by Retinal vessel analyzer (RVA), Heidelberg retinal Flowmeter (HRF) and the Ocular blood Flowmeter (OBF) before, during and after standardized specific acupuncture at healthy voluntee...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • persons over 18 years, men or women, diabetic diagnostics within the last year
- Exclusion Criteria:
- • medical use of anticoagulative substances, use of dorzolamide, use of immunosuppressive medication
- • psychiatrics, epileptics
About Technische Universität Dresden
Technische Universität Dresden (TU Dresden) is a leading research institution in Germany, renowned for its commitment to advancing scientific knowledge and innovation across various disciplines, including medicine and healthcare. As a clinical trial sponsor, TU Dresden leverages its cutting-edge research facilities and interdisciplinary expertise to facilitate the development of novel therapeutic interventions and improve patient outcomes. The university fosters collaboration among academic, clinical, and industry partners, ensuring rigorous adherence to ethical standards and regulatory requirements in the conduct of clinical research. Through its dedication to excellence and research-driven initiatives, TU Dresden plays a pivotal role in translating scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dresden, Saxonia, Germany
Patients applied
Trial Officials
Janek - Haentzschel, Dr.
Study Director
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials